Capricor Therapeutics
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -20,359 | |||
EBITDA | 255,153 | -33,406 | 976,239 | -24,075 |
EBIT | -40,732 | -33,941 | -27,125 | -24,570 |
Net Income | -40,733 | -33,941 | -30,170 | -24,570 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -37,386 | -40,001 | -28,691 | -23,698 |
Cash | 20,935 | 105,421 | 287,847 | 19,510 |
Basic Shares | 57,926 | 57,434 | 48,850 | 45,716 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $22,270 | $25,178 | $2,551 |
Gross Profit | -27,698 | -11,269 | -19,265 | |
EBITDA | -100,109 | -39,041 | -21,218 | -28,486 |
EBIT | -101,998 | -40,467 | -22,287 | -29,019 |
Net Income | -105,043 | -40,467 | -22,287 | -29,019 |
Net Change In Cash | 0 | 22,270 | 25,178 | 2,551 |
Cost of Revenue | -25,282 | |||
Free Cash Flow | -72,715 | -41,534 | -27,644 | 1,556 |
Cash | 287,847 | 11,286 | 14,694 | 9,603 |
Basic Shares | 46,478 | 35,219 | 26,778 | 24,552 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.70 |
2026-03-31 | -$0.59 |
2025-12-31 | -$0.62 |
2025-09-30 | -$0.54 |